AI assistant
BPH ENERGY LTD — Capital/Financing Update 2009
Oct 1, 2009
64555_rns_2009-10-01_42deaee0-fce2-4bb2-8196-e2138f58cfb1.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [150 x 78] intentionally omitted <==
2[nd] October 2009
Companies Announcements Office Australian Securities Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000
Dear Shareholder,
MOLECULAR DISCOVERY SYSTEMS SPIN OFF AND IPO
As previously announced BioPharmica intends to seek an IPO for Molecular Discovery Systems (MDS) on the Australian Securities Exchange.
Under a planned ‘spin off’ process, BioPharmica (ASX Code: BPH) shareholders would receive a share at no cost in Molecular Discovery Systems for every listed BioPharmica share that they hold five days after the date of shareholder approval being obtained for the spin off (record date). Shareholder approval will be sought at the 2009 Annual General Meeting which is anticipated to be held on 12th November 2009. Shareholders must hold their shares at the record date to be entitled to their free shares in MDS . The anticipated timetable for the spin off has been provided below.
The spin off and listing is subject to approval from shareholders and regulatory bodies.
Anticipated Timetable
| Event | Anticipated Date |
|---|---|
| AnnualGeneral Meeting | 12th November 2009 |
| Shareholder Approval Received | 12th November 2009 |
| RecordDateforSpinOffShares | 5.00pm 19th November 2009 |
The directors of BPH would once again like to thank its shareholders for their continued support after the recently closed Shareholder Share Purchase Plan. The plan was a great success raising $2,730,000 which was equal to a 93% take up of the plan.
Yours Sincerely
==> picture [127 x 46] intentionally omitted <==
David Breeze Managing Director
BioPharmica Limited ACN 95 912 002 PO Box 317, North Perth, Western Australia 6906 14 View Street, North Perth, Western Australia 6006 [email protected] www.biopharmica.com.au T: +61 8 9328 8366 F: +61 8 9328 8733